 The purpose of the study is to determine whether extended-release oxymorphone hydrochloride taken orally with a high-fat meal, generating an approximately 50 higher Cmax, impacts cognitive functioning, using Cambridge Neuropsychological Test Automated Battery CANTAB tests, to a greater extent than when taking under conditions of fasting. 